CompletedNot Applicable

XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice

South Korea4,000 participantsStarted 2014-05

Plain-language summary

The purpose of this study is to evaluate effectiveness and safety of XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice

Who can participate

Age range19 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 19 and more * Intervention with XIENCE Xpedition or Alpine or Sierra everolimus eluting coronary stent * Agreed with written informed consent form Exclusion Criteria: * Intervention with XIENCE Xpedition or Alpine or Sierra everolimus eluting coronary stent and other drug eluting stent at the same time * Life expectancy of 1year and under * Cardiac shock

What they're measuring

Composite event rate

Timeframe: 1year

Trial details

NCT IDNCT02042300

SponsorSeung-Jung Park

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-07

View on ClinicalTrials.gov More Percutaneous Transluminal Coronary Angioplasty trials